CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescenc
The recent discovery of CALR mutations in essential thrombocythemia (ET) and primary myelofibrosis (...
AbstractInsertion and/or deletion mutations of the CALR gene have recently been demonstrated to be t...
Somatic CALR mutations occur in approximately 70% of patients with JAK2 V617F-negative essential thr...
CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescenc
After the recent discovery of various mutations of theCALRgene,,10% of adult patients with essential...
The JAK2 V617F mutation, the thrombopoietin receptor MPL W515K/L mutation and the Calreticulin (CALR...
The JAK2 V617F mutation, the thrombopoietin receptor MPL W515K/L mutation and calreticulin (CALR) mu...
Somatic mutations in the calreticulin (CALR) gene were recently discovered in patients with sporadic...
CALR (calreticulin) trails JAK2 as the second most mutated gene in essential thrombocythemia (ET). M...
In this issue of Blood, Shide et al separate the roles of loss of a normal CALR allele and gain of a...
Patients with essential thrombocythemia may carry JAK2 (V617F), an MPL substitution, or a calreticul...
Carta a l'editorWe studied the role of the recently identified CALR mutations in 141 patients with B...
Polycythemia vera (PV) and essential thrombocythemia (ET) are Philadelphia-negative myeloproliferati...
Background: Recently, calreticulin (CALR) gene mutations have been identified in patients with essen...
Insertion and/or deletion mutations of the CALR gene have recently been demonstrated to be the secon...
The recent discovery of CALR mutations in essential thrombocythemia (ET) and primary myelofibrosis (...
AbstractInsertion and/or deletion mutations of the CALR gene have recently been demonstrated to be t...
Somatic CALR mutations occur in approximately 70% of patients with JAK2 V617F-negative essential thr...
CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescenc
After the recent discovery of various mutations of theCALRgene,,10% of adult patients with essential...
The JAK2 V617F mutation, the thrombopoietin receptor MPL W515K/L mutation and the Calreticulin (CALR...
The JAK2 V617F mutation, the thrombopoietin receptor MPL W515K/L mutation and calreticulin (CALR) mu...
Somatic mutations in the calreticulin (CALR) gene were recently discovered in patients with sporadic...
CALR (calreticulin) trails JAK2 as the second most mutated gene in essential thrombocythemia (ET). M...
In this issue of Blood, Shide et al separate the roles of loss of a normal CALR allele and gain of a...
Patients with essential thrombocythemia may carry JAK2 (V617F), an MPL substitution, or a calreticul...
Carta a l'editorWe studied the role of the recently identified CALR mutations in 141 patients with B...
Polycythemia vera (PV) and essential thrombocythemia (ET) are Philadelphia-negative myeloproliferati...
Background: Recently, calreticulin (CALR) gene mutations have been identified in patients with essen...
Insertion and/or deletion mutations of the CALR gene have recently been demonstrated to be the secon...
The recent discovery of CALR mutations in essential thrombocythemia (ET) and primary myelofibrosis (...
AbstractInsertion and/or deletion mutations of the CALR gene have recently been demonstrated to be t...
Somatic CALR mutations occur in approximately 70% of patients with JAK2 V617F-negative essential thr...